Individualized precision medicine in the ICU Including the organ function of our immune system into the daily routine

Individualized precision medicine in the ICU Including the organ function of our immune system into the daily routine - iSOFA-Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025983

Enrollment

200

Registered

2021-08-12

Start date

2022-03-01

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondary infections on ICU

Interventions

Group 1: mHLA-DR and other inflammatory markers every 72h

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Lack of consent, consent only after manifestation of secondary infection, patients included in intervention studies, patients < 18 years of age.

Exclusion criteria

Exclusion criteria: Lack of consent, consent only after manifestation of secondary infection, patients included in intervention studies, patients < 18 years of age.

Design outcomes

Primary

Measure	Time frame
Development of a secondary Infection	—

Secondary

Measure	Time frame
Mortality	—

Countries

Germany

Contacts

Public ContactSteffen Dickel

Klinik für AnästhesiologieUniversitätsmedizin Göttingen

steffen.dickel@med.uni-goettingen.de+4955166045

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026